Loading…
Loading…
FBT has outperformed RSPH by a wide margin recently. The question is whether you want to own the fund that won last year or the one built to hold up over many years.
Invesco S&P 500 Equal Weight Health Care ETF offers a lower expense ratio and a higher dividend yield than iShares Biotechnology ETF. iShares Biotechnology ETF provides concentrated biotech exposure while Invesco S&P 500 Equal Weight Health Care ETF covers the broader healthcare sector.
RSPH hits a new 52-week high, rising 29.5% from its low as resilient healthcare demand, solid earnings and defensive-sector appeal fuel momentum.
Healthcare stocks have finally stepped back into the spotlight. After spending much of the past several years in the shadow of technology and AI, the sector has quietly emerged as one of the year's more compelling comeback stories.
Avidian Wealth Enterprises LLC acquired a new stake in Invesco S&P 500 Equal Weight Health Care ETF (NYSEARCA:RSPH) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 15,640 shares of the company's stock, valued at approximately $579,000. Avidian
The Invesco S&P 500 Equal Weight Health Care ETF offers a lower expense ratio and broader diversification than the Invesco Pharmaceuticals ETF. The Invesco Pharmaceuticals ETF has generated higher 1-year and 5-year total returns while maintaining lower price volatility.
Looking for broad exposure to the Healthcare - Broad segment of the equity market? You should consider the Invesco S&P 500 Equal Weight Health Care ETF (RSPH), a passively managed exchange traded fund launched on November 1, 2006.
PBE offers a higher dividend yield and has delivered stronger one-year total returns. RSPH offers a more affordable expense ratio and a significantly lower historical drawdown.
SEC filings for RSPH aren't indexed yet (common for recently launched funds). Browse the issuer's filings on SEC EDGAR directly.